• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

The Longevity+DeSci Summit: Advancing the Frontiers of Longevity Science

Microdose by Microdose
September 13, 2023
in Industry
Reading Time: 3 mins read
A A
The Longevity+DeSci Summit: Advancing the Frontiers of Longevity Science

The Microdose team attended the Longevity+DeSci Summit NYC, held on August 10-11, 2023. This groundbreaking conference brought together leaders in aging research, biotechnology, and decentralized science. Organized by the nonprofit Lifespan.io, this event showcased the latest advances at the intersection of longevity science and emerging technologies like blockchain. Two days of fascinating talks, workshops, and discussions that revealed the tremendous potential of extending healthy human lifespans.

The event took place at the magnificent Capitale venue in New York City, the Summit exhibitions and presentations highlighted trailblazing work on the fundamental biology of aging, biomarkers, AI applications, decentralized research platforms, and more. Attendees also had the opportunity to learn about novel approaches to fundraising, community-building, and scientific communication enabled by blockchain technology and decentralized organizations.

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

A Catalyst for Collaboration

Some of the most prominent voices in longevity science were featured speakers, including Aubrey de Grey of LEVF, Harvard Professor Vadim Gladyshev, and Altos Labs’ Steve Horvath. They delivered insights into cutting-edge areas like rejuvenation biotechnology, cellular senescence, and epigenetic clocks. Other researchers presented late-breaking discoveries on topics such as clearing toxic molecular waste from cells and targeting the microbiome to influence aging processes.

Visionary entrepreneurs also took the stage to discuss how they are translating longevity research into real-world interventions. This included updates on progress towards clinical trials, commercial products, and other developments from companies like Gero, Maxwell Biosciences, quadraScope, AgelessRx and others. The theme of moving from pure science into medical applications was a major focus.

The session that got us thinking the most was ‘’Starting A Longevity City’’ by Niklas Anzinger, Infinita VC – General Partner and Laurence Ion, Steward at VitaDAO. Niklas and Laurence introduced Vitalia – the Frontier City of Life. Inspired by Zuzalu, Vittalia will start as a 2-month long co-living experiment. It will take place on a beautiful Caribbean island, in a place with perfect conditions to advance progress in longevity science and technology development.

 

Decentralized Science

Equally important was the emphasis on leveraging decentralized models to accelerate research. Experts from prominent organizations like VitaDAO, Weavechain, and ResearchHub explained how blockchain tools can enhance collaboration, crowd-sourced funding, and open access data. Workshops gave attendees hands-on practice with building digital cooperatives and using crypto to support scientific initiatives.

Overall, the Longevity+DeSci Summit NYC provided an exhilarating look at the tools and knowledge that could enable radical improvements to human health spans. Connecting trailblazers across various specialties revealed the synergies emerging in this dynamic arena. From AI-assisted drug discovery to decentralized clinical trials, innovative approaches are converging to tackle the diseases of aging.

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Dynamic Programming

Order Lasix By Mail

Lifespan.io and conference organizers succeeded in curating a program that was both comprehensive in scope and deeply insightful. The mix of presentations, panel discussions, and interactive elements kept attendees engaged.

For any professionals or members of the public interested in being part of the longevity movement, this was an invaluable opportunity. The caliber of talent and ideas on display showed how rapidly the field is evolving. And the sense of optimism and collaboration amongst participants was palpable.

The Longevity+DeSci Summit NYC produced by Lifespan.io advanced the goal of healthy life extension through showcasing top science, fostering productive connections, and spurring further innovation. Initiatives like this that bring stakeholders together will be key to translating visionary ideas into real societal impact. Based on the success of this conference, the future looks very bright for extending healthy human longevity using cutting-edge biomedicine and technology.

 

How to Support Lifespan.io?

Donate: Your donations directly fuel Lifespan.io’s high-impact programs and initiatives and help us bring life-changing breakthroughs closer to reality. Even a small contribution can make a big difference.

Stay Informed: Sign up for the Lifespan.io newsletter to receive the latest longevity biotech news, interviews, and more!

Additional Lifespan.io resources and links

Connect with us on social media @lifespanio

Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
maps

MAPS Publishes Results of Successful Phase 3 Trial

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.